GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Infant Bacterial Therapeutics IBT B.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

72.80

-1.09%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Infant Bacterial Therapeutics annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In SEK.

FY2025FY2024FY2023FY2022FY2021
Revenue—SEK 4,000SEK 77,000SEK 12,000—
Operating income−SEK 62.0m−SEK 139.9m−SEK 134.6m−SEK 65.8m−SEK 44.6m
Net income−SEK 65.2m−SEK 136.9m−SEK 123.1m−SEK 65.5m−SEK 45.0m
Free cash flow−SEK 72.3m−SEK 113.1m−SEK 101.2m−SEK 85.8m−SEK 55.6m
Total assetsSEK 161.7mSEK 239.6mSEK 351.3mSEK 349.6mSEK 408.5m
Shareholders' equitySEK 105.3mSEK 170.3mSEK 305.2mSEK 331.7mSEK 395.3m

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.